Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)

NCT06709521 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

NIH

Sponsor class

Conditions

Bacterial Infection

Interventions

DRUG: Iohexol

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)